Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Oric Pharmaceuticals, Inc.

ORIC · Nasdaq · CIK 0001796280 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

15 Form 4 transaction lines observed in the same window
9 sales · 6 option, withholding, award, gift or other lines

Last qualifying purchase2025-06-23 · You Angie · $13.2K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Piscitelli DominicChief Financial Officer
○▼○▼○▼
Heyman Richard A.Director
▼○▼○▼
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-06-23 · You Angie.

Recent Form 4 activity

0Purchases
15Sales
12Other Form 4 lines
13SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING9 sale line(s) · context only
OTHER6 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
16,315,970
Previous report
17,532,473
Avg daily volume
1,655,964
Days to cover
9.8

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-06-23You AngiePurchase (P)Common Stock1,403USD 9.43USD 13,230SEC filing ↗
2025-06-20You AngiePurchase (P)Common Stock26,597USD 9.39USD 249,746SEC filing ↗
2022-05-13Chacko JacobPurchase (P)Common Stock76,072USD 2.82USD 214,523SEC filing ↗
2022-05-12Chacko JacobPurchase (P)Common Stock69,354USD 2.75USD 190,724SEC filing ↗
2022-05-11Chacko JacobPurchase (P)Common Stock304,574USD 2.90USD 883,265SEC filing ↗
2022-03-31Piscitelli DominicPurchase (P)Common Stock60,000USD 5.36USD 321,600SEC filing ↗
2022-03-25Chacko JacobPurchase (P)Common Stock50,000USD 4.54USD 227,000SEC filing ↗
2022-03-24Chacko JacobPurchase (P)Common Stock42,873USD 5.03USD 215,651SEC filing ↗
2022-03-23Chacko JacobPurchase (P)Common Stock257,127USD 4.98USD 1,280,492SEC filing ↗
2020-04-24ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLCPurchase (P)Common Stock281,250USD 16.00USD 4,500,000SEC filing ↗
2020-04-24GORDON CARL LPurchase (P)Common Stock281,250USD 16.00USD 4,500,000SEC filing ↗

Form 4 evidence

27 transaction lines in the latest 365-day window; 189 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-01Heyman Richard A.Sale (S)Common Stock6,700USD 12.91USD 86,524SEC filing ↗
2026-10-01Heyman Richard A.Option exercise / conversion (M)Common Stock3,500USD 1.60USD 5,600SEC filing ↗
2026-09-28Piscitelli DominicSale (S)Common Stock13,400USD 13.53USD 181,302SEC filing ↗
Show recent Form 4 evidence (22 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-01Heyman Richard A.Sale (S)Common Stock6,700USD 12.91USD 86,524SEC filing ↗
2026-10-01Heyman Richard A.Option exercise / conversion (M)Common Stock3,500USD 1.60USD 5,600SEC filing ↗
2026-09-28Piscitelli DominicSale (S)Common Stock13,400USD 13.53USD 181,302SEC filing ↗
2026-09-28Piscitelli DominicOption exercise / conversion (M)Common Stock13,400USD 4.36USD 58,424SEC filing ↗
2026-09-24Piscitelli DominicSale (S)Common Stock600USD 13.51USD 8,105SEC filing ↗
2026-09-24Piscitelli DominicOption exercise / conversion (M)Common Stock600USD 4.36USD 2,616SEC filing ↗
2026-08-26Piscitelli DominicSale (S)Common Stock77,000USD 13.69USD 1,054,130SEC filing ↗
2026-08-26Piscitelli DominicOption exercise / conversion (M)Common Stock77,000USD 4.89USD 376,720SEC filing ↗
2026-07-24Heyman Richard A.Sale (S)Common Stock13,100USD 12.02USD 157,462SEC filing ↗
2026-07-24Heyman Richard A.Option exercise / conversion (M)Common Stock3,500USD 1.60USD 5,600SEC filing ↗
2026-07-06Heyman Richard A.Sale (S)Common Stock300USD 12.00USD 3,600SEC filing ↗
2026-02-24Piscitelli DominicSale (S)Common Stock52,000USD 13.51USD 702,520SEC filing ↗
2026-02-24Piscitelli DominicOption exercise / conversion (M)Common Stock52,000USD 4.36USD 226,720SEC filing ↗
2026-01-16Heyman Richard A.Sale (S)Common Stock6,700USD 12.00USD 80,400SEC filing ↗
2025-12-16Piscitelli DominicSale (S)Common Stock10,720USD 9.06USD 97,123SEC filing ↗
2025-12-16Multani Pratik SSale (S)Common Stock10,720USD 9.06USD 97,123SEC filing ↗
2025-12-16Chacko JacobSale (S)Common Stock33,374USD 9.06USD 302,368SEC filing ↗
2025-12-15Piscitelli DominicOption exercise / conversion (M)Common Stock29,333USD 0.00USD 0SEC filing ↗
2025-12-15Multani Pratik SOption exercise / conversion (M)Common Stock29,333USD 0.00USD 0SEC filing ↗
2025-12-15Chacko JacobOption exercise / conversion (M)Common Stock83,666USD 0.00USD 0SEC filing ↗
2025-12-08Kunkel Lori AnneOption exercise / conversion (M)Common Stock10,000USD 7.90USD 79,000SEC filing ↗
2025-12-04Kunkel Lori AnneOption exercise / conversion (M)Common Stock5,534USD 3.75USD 20,752SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerORIC
CIK0001796280
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history189 transaction lines from 2020-04-24 to 2026-10-01
11 P purchase lines · 125 S sale lines · 53 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.